Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
Taku Sakurai(Takeda (Japan)), Matt Barnes(Takeda (United Kingdom)), Sarah Bousba(Takeda (United Kingdom)), Mathew Leveridge(Takeda (United Kingdom)), Stuart Stafford(Takeda (United Kingdom)), Alka Parmar(Takeda (United Kingdom)), Kazumasa Ogawa(Takeda (Japan)), Junji Matsui(Eisai (Japan)), Andy Sykes(Takeda (United Kingdom)), Stephen C. Mack(Hospital for Sick Children), Laura E. Parton(Takeda (United Kingdom)), Jennifer Cameron(Takeda (United Kingdom)), David Harrison(University of Notre Dame), Louise Dickson(Takeda (United Kingdom)), Richard Davenport(Takeda (United Kingdom)), Johannes Grosse(Takeda (United Kingdom))
Cited by 54
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
|British Journal of Cancer|2014|355
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
|Cancer Medicine|2018|258
Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells
|Journal of Biological Chemistry|2004|217